Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison, Andy M. Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Erich M. Sturgis, Barbara Burtness, John A. Ridge, Jolie Ringash, James Galvin, Min Yao, Shlomo A. Koyfman, Dukagjin M. Blakaj, Mohammed A. Razaq, A. Dimitrios Colevas, Jonathan J. Beitler, Christopher U. Jones, Neal E. Dunlap, Samantha A. SeawardSharon Spencer, Thomas J. Galloway, Jack Phan, James J. Dignam, Quynh Thu Le
Dive into the research topics of 'Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial'. Together they form a unique fingerprint.